Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin

Journal of the American Animal Hospital Association

Volumn 43, Issue 6, 2007, Pages 337-341

  Wildermuth, Brett Everett ^a   Griffin, Craig E ^a   Rosenkrantz, Wayne S ^b   Boord, Mona J ^a  

^a Animal Dermatology Clinic   (United States)

^b Animal Dermatology Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS; PSEUDOMONAS;

ANTIINFECTIVE AGENT; CIPROFLOXACIN; ENROFLOXACIN; MARBOFLOXACIN; QUINOLONE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL SKIN DISEASE; DOG; DOG DISEASE; DOSE RESPONSE; DRUG EFFECT; EXTERNAL OTITIS; FEMALE; GRAM NEGATIVE INFECTION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PSEUDOMONAS; PYODERMA; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; MALE; MICROBIAL SENSITIVITY TESTS; OTITIS EXTERNA; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; PYODERMA; QUINOLONES; RETROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; TREATMENT OUTCOME;

EID: 38449117538     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0430337     Document Type: Article

References (20)

1. Bergogne-Berezin E. Pseudomonas and miscellaneous gram-negative bacilli. In: Cohen J, Powderly WG, eds. Infectious Diseases. 2nd ed. London: Mosby, 2004:2203-2226.
2. Griffin CE. Otitis externa and otitis media. In: Griffin CE, Kwochka KW, MacDonald JM, eds. Current Veterinary Dermatology. St. Louis: Mosby, 1993:245-262.
3. Scott DW, Miller WH, Griffin CE. Muller and Kirk's Small Animal Dermatology. 6th ed. Philadelphia: WB Saunders, 2001.
4. Seol B, Naglic T, Madic J, et al. In vitro antimicrobial susceptibility of 183 Pseudomonas aeruginosa strains isolated from dogs to selected antipseudomonal agents. J Vet Med B Infect Dis Vet Public Health 2002;49:188-192.
5. Martin JL, Lupiola P, Gonzalez Z, et al. Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa. J Vet Med B Infect Dis Vet Public Health 2000;47:191-196.
6. Colombini S, Merchant SR, Hosgood G. Microbial flora and antimicrobial susceptibility patterns from dogs with otitis media. Vet Dermatol 2000;11:235-239.
7. Petersen AD, Walker RD, Bowman MM, et al. Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). J Am Anim Hosp Assoc 2002;38:407-413.
8. Meunier D, Acar JF, Martel JL, et al. A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets. Int J Antimicrob Agents 2004;24:592-598.
9. Ihrke PJ, Papich MG, DeManuelle TC. The use of fluoroquinolones in veterinary dermatology. Vet Dermatol 1999;10:193-204.
10. Boothe MD. Clinical Pharmacology and Therapeutics. Philadelphia: WB Saunders, 2001:162-166.
11. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001;7:337-341.
12. Ewing WH. Edwards and Ewing's Identification of Enterobacteriaceae. 4th ed. New York: Elsevier Science, 1986.
13. National Committee of Clinical Labolratory Science. NCCLS guidelines for susceptibility testing by disk diffusion. January M00;20:M7-A5.
14. Jones RN, Kirby JT, Beach ML, et al. Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2002; 43:239-243.
15. Thomson CJ. The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective. J Antimicrob Chemother 1999;43 (Suppl A):31-40.
16. Cole LK, Kwochka KW, Kowalski JJ, et al. Microbial flora and antimicrobial susceptibility patterns of isolated pathogens from the horizontal ear canal and middle ear in dogs with otitis media. J Am Vet Med Assoc 1998;212:534-538.
17. Kohler T, Michea-Hamzehpour M, Plesiat P, et al. Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1997;41:2540-2543.
18. Tejedor MT, Martin JL, Navia M, et al. Mechanisms of fluoroquinolone resistance in Pseudomonas aeraginosa isolates from canine infections. Vet Microbiol 2003;94:295-301.
19. Morlet PS, Apley MD, Besser TE, et al. Antimicrobial drug use in veterinary medicine. J Vet Intern Med 2005;19:617-629.
20. American Veterinary Medical Association Judicious Therapeutic Use of Antimicrobials. American Veterinary Medical Association, http://www.avma.org/scienact/jtua/jtua98.asp, accessed 1/14/2006.